Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study. - Wikidata - wikimedia - TriplyDB

Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study.

Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study.

http://www.wikidata.org/entity/Q31133255

about

Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study.

http://www.wikidata.org/entity/Q31133255

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Real-life use of digoxin in pa ...... n: data from the RAMSES study.

@ast

Real-life use of digoxin in pa ...... n: data from the RAMSES study.

@en

type

label

Real-life use of digoxin in pa ...... n: data from the RAMSES study.

@ast

Real-life use of digoxin in pa ...... n: data from the RAMSES study.

@en

prefLabel

Real-life use of digoxin in pa ...... n: data from the RAMSES study.

@ast

Real-life use of digoxin in pa ...... n: data from the RAMSES study.

@en

P1433

Q31133255-3CC7E601-8F9D-4595-B853-471EA4846675

P1476

Q31133255-EFBF1654-EED3-4F5B-AAEB-AA9EFF5D1329

P2093

Q31133255-034F07DB-49BB-41C3-8854-07EC7D5BE28A

Q31133255-0582DED2-8085-4923-80BC-02F4EE226990

Q31133255-114B08E0-4999-4EE0-BD46-D36ACF7CEF52

Q31133255-1495F53C-1AB8-4E09-98F3-BB31D94E2A99

Q31133255-25F2977A-6545-48CE-BAA5-5422F28DC68D

Q31133255-288386D9-5C84-4B9F-8904-F85F9E3782D5

Q31133255-5B5D1795-B182-4658-BCBD-5D92741738ED

Q31133255-7649DE45-2F77-4776-A2AB-5037A162D552

Q31133255-77AEDB8C-E633-4F11-8ACD-56BD866BF61E

Q31133255-9A3F1BE6-EB8C-4F0E-8993-36A3CCCEF7B5

P2860

Q31133255-03F86EE5-6F94-4390-81A9-3285E8C4E518

Q31133255-1A4F8BD1-DDAB-4AEB-957D-BF3213EBA069

Q31133255-23C2DDBC-0253-4B8B-8F1D-AE625EC20259

Q31133255-25D61858-6522-4682-947F-CF43D3174540

Q31133255-308D459D-3F64-4027-940B-1896AB19671E

Q31133255-351750C3-2AE5-4C1B-9B4F-CC8D1FA3729B

Q31133255-469DAD26-08AF-450A-8D17-CC52885E3E0F

Q31133255-47866B17-B7A7-4807-AAEC-E54A3E3A0E20

Q31133255-53309594-81DC-499C-ADF0-950F7BD8F42A

Q31133255-5B2180C5-41EC-46A6-9721-417DC7E349D7

P304

Q31133255-EF6D80D5-B738-453D-A9C3-AF456AA8C537

P31

Q31133255-E55B0386-1F9A-416F-84AF-151E746F2254

P356

Q31133255-D0DA9928-FF92-4D58-8749-1FFAB1BA8512

P433

Q31133255-20AE8F74-4D61-4374-9357-28E794331289

P478

Q31133255-1030DC12-BF0E-4CA7-9216-5B9AFC8C193A

P50

Q31133255-72CAC5E7-A7B2-4890-B9A7-522170EFC512

P577

Q31133255-8B420B9E-0BD7-4B16-9FFC-47603C52AA42

P698

Q31133255-296ADE20-DA00-47EF-869E-023AC956677E

P921

Q31133255-748AD255-AB6F-43B4-ACF0-32481695776E

P356

P1433

Journal of Clinical Pharmacy and Therapeutics

P1476

Real-life use of digoxin in pa ...... n: data from the RAMSES study.

@en

P2093

A Çağrı Aykan

http://www.w3.org/2001/XMLSchema#string

C Kırma

http://www.w3.org/2001/XMLSchema#string

E Kalaycıoğlu

http://www.w3.org/2001/XMLSchema#string

I Bolat

http://www.w3.org/2001/XMLSchema#string

M Biteker

http://www.w3.org/2001/XMLSchema#string

M Kalçık

http://www.w3.org/2001/XMLSchema#string

M Tekinalp

http://www.w3.org/2001/XMLSchema#string

M Yaman

http://www.w3.org/2001/XMLSchema#string

O Beton

http://www.w3.org/2001/XMLSchema#string

O TaŞar

http://www.w3.org/2001/XMLSchema#string

P2860

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Medication misadventures in the elderly: a year in review.

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tr

An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients.

Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort

Digoxin: A systematic review in atrial fibrillation, congestive heart failure and post myocardial infarction

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.

Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis.

P304

711-717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCPT.12460

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27671101

http://www.w3.org/2001/XMLSchema#string

P921